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Background: The objective of the study is to evaluate the influence of serum vitamin D concentrations and
smoking status in cardiac structure and function.
Methods: The participants of this study were healthy women smokers (n = 18, mean age 52.8 years), ex-smokers (n= 18,
mean age 51.7 years), and never smokers (n = 19, mean age 44.4 years). All participants underwent assessment of body
composition, dietary intake, sun exposure frequency, vitamin D serum determination, and echocardiographic assessment.
All data underwent statistical analysis.
Results: The three groups were classified as overweight. The group of ex-smokers showed significantly higher vitamin D
serum concentrations. Smoker group showed a higher posterior wall thickness (PW), left ventricular mass, and left
ventricular mass index (LVMI). We identified positive correlations between LVMI and smoking history, PW and
vitamin D serum, and body mass index and time of smoking history. Multiple linear regressions showed positive
association of smoking history and LVMI and PW, also that serum vitamin D has a positive association with PW.
PW was associated with smoking history and serum vitamin D, showing a deleterious effect on the heart of both
variables.
Conclusions: Smoking habit in adult women was associated with cardiac remodeling, and excess of vitamin D
is associated with the action of smoking on cardiac variables. Thus, higher serum vitamin D values have a deleterious
effect on the heart in this model.
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More than one billion individuals worldwide are esti-
mated to have vitamin D deficiency [1]. Additionally, the
list of disorders associated with vitamin D deficiency
continues to grow [2]. In addition to its classical func-
tions, vitamin D deficiency is associated with cancer,
neurodegenerative diseases, cardiovascular diseases, and
mortality of all causes [3–6]. Vitamin D deficiency is de-
scribed as a potential risk factor for cardiovascular dis-
ease, primarily ventricular hypertrophy and congestive
heart failure [3, 7, 8]. Recently, an experimental study* Correspondence: melainepf@gmail.com
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with cardiac hypertrophy as well as reduced left ven-
tricular fractional shortening and ejection fraction [9].
Furthermore, Mancuso et al. [10] showed an attenuation
of cardiac hypertrophy when rats with heart failure re-
ceived chow with vitamin D supplementation.
Together with deficiency/excess vitamin D, smoking is a
risk factor for cardiovascular disease and is the primary
cause of preventable death worldwide [11]. Cigarette
smoke is thrombogenic, atherogenic, and promotes direct
aggression to the heart [12]. Experimental studies showed
that animals exposed to cigarette smoke have cardiac al-
terations also known as cardiac remodeling [13–16]. Clin-
ical studies also showed the effects of cigarette smoking
on ventricular remodeling and heart function [17, 18].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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min D and tobacco smoke exposure. Hill et al. [19] ob-
served in a clinical study that smoking was negatively
associated with serum vitamin D concentrations in Irish
women and in Australia, smokers had lower levels of
serum vitamin D [20]. Moreover, Rafacho et al. [16] sup-
plemented cigarette-smoke-exposed rats with vitamin D
and observed an attenuation of cardiac remodeling. This
study suggests that vitamin D status could influence car-
diac alterations caused by tobacco smoke. Thus, the hy-
pothesis of this study is that vitamin D deficiency could
worsen cardiac alterations induced by cigarette smoke.
Objective
The objective of the study is to evaluate the influence of
serum vitamin D concentrations and smoking status in
cardiac structure and function.
Methods
The study was approved by the ethics committee, and the
written informed consent was obtained from all of the
participants. The sample size was calculated based on the
average serum vitamin D concentration, an expectation of
a 3 ng/mL difference and a residual expected standard de-
viation of 2.8 ng/mL for comparing the three groups. As-
sumptions made were 80 % power and a significance
value of <0.05. Using these values, we obtained 18 subjects
per group.
A total of 18 active female smokers and 18 female ex-
smokers, who were participating in a smoking cessation
group, were evaluated. All of the participants, whether
smokers or ex-smokers, presented with a history of smok-
ing greater than ten pack-years. Ex-smokers were defined
as those who had stopped smoking for more than 6 months
before enrollment. Only women were evaluated because of
their higher prevalence in our smoking cessation program
and to obtain greater homogeneity between groups. The
control group consisted of 19 healthy women that were
never smokers. Exclusion criteria were as follows: presence
of severe or chronic diseases such as hypertension, dia-
betes, and respiratory diseases; supplementation of calcium
and vitamin D; age below 30 years old; body mass index
(BMI) higher than 30 kg/m2; and menopause.
Body composition assessment
Participant weight and height were measured, and BMI
was calculated (kg/m2). BMI was classified according to
the cutoff suggested by the WHO [21]. The fat-free mass
index (FFMI) and fat mass index (FMI) were estimated
(FFM/height2 and FMI/height2) based on dual-energy
X-ray absorptiometry exam (DXA) using the Hologic in-
strument, model Discovery A, Bedford, MA, USA. Auto-
mated quantification of regional body tissue weights was
performed with APEX System software version 2.3.1.Dietary intake assessment
To assess dietary vitamin D intake, a 24-h recall was used
in triplicates. Data from the three food records were
calculated using the Nutrition Data System for Research-
Grad Pack Software, which was developed by the Nutri-
tion Coordinating Center (NCC), University of Minnesota,
Minneapolis, MN.
Sun exposure assessment
A sun exposure frequency questionnaire was used to
analyze the sun exposure of participant. Each answer
contained a value defined as an index of sun exposure
ranging from 0 (no sun exposure) to 38 (high sun ex-
posure) [22].
Biochemical assessment
Peripheral venous blood was obtained after a 12-h fast
in the early morning (8:00 to 10:00 a.m.) to collect
25(OH) vitamin D3, calcium, and parathyroid hormone
(PTH) levels. 25(OH) vitamin D3 levels were measured
by chemiluminescence (Abbott®). Vitamin D deficiency
was defined as serum vitamin D levels lower than 12 ng/
mL. Risk for inadequacy was defined as serum levels of
25(OH) vitamin D3 from 12 to 20 ng/mL, and sufficient
levels were above 20 ng/mL [23].
Echocardiographic assessment
Transthoracic echocardiography was performed to evalu-
ate cardiac morphology and function by the same oper-
ator. The echocardiograph was a General Electric (GE)
equipment Vivid 6S with phased-array multifrequency
transducers of 2.5 to 3.5 MHz and an image registration
system. Images were obtained and analyzed following the
recommendations of the American Society of Echocardi-
ography [24]. Intraobserver variability was lower than
3 %. Left ventricular systolic function was evaluated by
measuring the ejection fraction according to the Simp-
son method.
Statistical analysis
ANOVA test was used to compare means between the
three groups when the distribution was normal, followed
by Tukey’s test for pairwise comparisons. The Kruskal-
Wallis test followed by Dunn’s test was used to compare
variables with nonparametric distribution. Pearson’s or
Spearman’s correlation coefficients were used to examine
associations between continuous variables according to
their distribution. χ2 was used to compare proportions.
Multiple linear regression analyses were used to evaluate
the influence of vitamin D and smoking status on echo-
cardiographic variables. Statistical significance was con-
sidered when p < 0.05. SPSS version 12.0 was used
(Statistical Package for Social Science, IBM).
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We evaluated 64 women, of whom nine were excluded
due to diabetes (two subjects), chronic obstructive pul-
monary disease (one subject), and BMI > 30 kg/m2 (six
subjects). Thus, 55 women completed the study protocol.
The average age of the women smokers and ex-smokers
was greater than 50 years old. The women in the three
groups were classified as overweight. The history of smok-
ing was similar between smokers and ex-smokers (Table 1).
There were no differences in body composition vari-
ables (FFMI and FMI) and vitamin D intake among the
three groups. The sun exposure frequency questionnaire
showed that the smoking subjects (smokers and ex-
smokers) had a higher total score compared with the
control subjects (Table 1).
Generally, most women studied showed sufficient vita-
min D concentrations 65.5 %), and the proportions
among the groups were not different. Furthermore, ex-
smokers showed significantly higher vitamin D concen-
trations than the control group.
Echocardiographic morphometric variables are presented
in Table 2. The smoker group showed a higher posterior
wall thickness (PW), left ventricular mass (LVM), and left
ventricular mass index (LVMI) compared with the control
group. No differences were observed when comparing the
other variables among the groups.
Variables to evaluate systolic and diastolic function are
also presented in Table 2. We observed that the ex-
smoker group had shorter E waves compared with the
control group. No differences were observed in other dia-
stolic function variables among the groups. There were
also no differences in systolic function variables among
the groups.
Correlations between LVMI, PW, serum vitamin D
concentrations, vitamin D intake, body composition, and
time of smoking are shown in Table 3. We identified
positive correlations between LVMI and smoking his-
tory, PW and serum vitamin D concentration, and BMI
and time of smoking history. Smoking history was usedTable 1 Clinical characteristics, smoking, and vitamin D status in the
Variables Control (n = 19) Sm
Age (years) 44.4 ± 11.0a 52
Smoking time (years) 0 31
BMI (kg/m2) 25.6 ± 3.7 26
FMI (kg/m2) 8.0 ± 2.6 8.6
FFMI (kg/m2) 16.9 ± 1.6 17
Vitamin D serum (ng/mL) 21.5 ± 6.4a 26
Vitamin D intake (μg/d) 4.2 ± 2.4 3.3
Freq sun expo 9.6 ± 4.5a 12
Values followed by different letters (a, b) differ at 5 % by the multiple comparison t
BMI body mass index, FMI fat mass index, FFMI fat-free mass index, Freq Sun Expo fr
*p < 0.05in statistical models because of the higher correlation
coefficient obtained in the univariate analysis (Table 3).
Multiple linear regressions revealed a positive association
of smoking history, LVMI, and PW (Table 4). Moreover,
serum vitamin D concentration was positively associated
with PW. Only PW was associated with smoking history
and serum vitamin D concentration, showing a deleterious
effect of both variables on the heart.
Discussion
The aim of this study was to evaluate the influence of
serum vitamin D concentrations and smoking status in
cardiac structure and function. Our results suggest that
tobacco smoke and higher vitamin D levels induced car-
diac remodeling.
Generally, the results showed that smokers and ex-
smokers were older than subjects in the control group.
The mean BMI classified the subjects as overweight, al-
though the literature cited studied smokers who were
underweight or are of normal weight [25]. Differences in
fat mass were not observed among groups. The groups
were also similar with respect to vitamin D intake; all
of them ingested vitamin D below the recommended
amount [23].
We observed significantly higher sun exposure indices
in the smoker and ex-smoker groups compared with the
control group. One possible explanation would be the
largest solar exposition caused by smoking habit. In São
Paulo state, an established law that prohibits smoking in
collective public or private environments forced smokers
to smoke in outdoors.
Circulating 25(OH) vitamin D3 concentration is the most
suitable indicator of vitamin D status. This prohormone is
stable and has a half-life of approximately 3 weeks [26].
However, the cutoff to define hypovitaminosis D is still not
well established. Some authors consider levels higher than
30 ng/ml to define sufficiency [5], while others consider
higher than 20 ng/mL an adequate cutoff level [23]. In this
study, we used the most recent classification of the IOM55 women studied
okers (n = 18) Ex-smokers (n = 18) p
.8 ± 7.0b 51.7 ± 8.0b 0.011*
.3 ± 10.9 28.4 ± 9.0 0.896
.0 ± 3.4 26.6 ± 2.7 0.636
± 2.2 9.2 ± 1.5 0.262
.2 ± 2.1 17.4 ± 1.6 0.745
.2 ± 10.4ab 30.2 ± 11.9b 0.033*
± 2.7 3.15 ± 1.9 0.327
.3 ± 4.6b 13.3 ± 3.9b 0.035*
est (Tukey’s test)
equency of sun exposure questionnaire
Table 2 Cardiac structure and diastolic and systolic functions of the 55 women studied, assessed by the echocardiography
Variables Control (n = 19) Smokers (n = 18) Ex-smokers (n = 18) p
LVD (mm) 37.0 ± 9.0 45.5 ± 4.41 44.5 ± 4.25 0.213
LVS (mm) 22.8 ± 1.78 26.8 ± 3.06 27.4 ± 3.75 0.493
PW (mm) 8.60 ± 0.54a 10.2 ± 2.13b 9.41 ± 1.53ab 0.023*
2PW/VED 0.49 ± 0.18 0.44 ± 0.66 0.42 ± 0.95 0.788
LVM (g) 115 ± 37.5a 208 ± 89.5b 173 ± 34.7ab 0.008*
LVMI 79.8 ± 21.8a 112 ± 36.4b 99.8 ± 18.6ab 0.002*
AD (mm) 27.2 ± 2.68 29.5 ± 2.34 29.4 ± 3.58 0.061
LAD (mm) 32.2 ± 2.04 35.7 ± 2.16 34.1 ± 3.83 0.175
LAD/AD 1.18 ± 0.96 1.21 ± 0.46 1.17 ± 0.20 0.844
Ejection fraction 0.77 (0.75–0.80) 0.77 (0.75–0.81) 0.77 (0.73–0.81) 0.985
Shortening fraction 0.33 ± 0.26 0.40 ± 0.61 0.38 ± 0.65 0.583
HR (bpm) 70.6 ± 4.09 72.0 ± 11.5 67.4 ± 8.88 0.391
CO (ml/min) 4562 ± 1405 4949 ± 1498 5002 ± 1333 0.550
E (cm/s) 84.4 ± 14.5a 71.8 ± 19.3ab 68.9 ± 19.1b 0.024*
A (cm/s) 74.0 ± 22.4 72.0 ± 18.4 59.9 ± 17.5 0.841
E/A 1.40 ± 0.57 1.01 ± 0.46 1.18 ± 0.53 0.196
Values followed by different letters (a, b) differ at 5 % by the multiple comparison test (Tukey’s test)
Abbreviations: LVD left ventricular diastolic diameter, LVS left ventricular systolic diameter, PW posterior wall thickness, 2PW/LVS relative wall thickness, LVM left
ventricular mass, LVMI left ventricular mass index, AD aortic diameter, LAD left atrium diameter, LAD/AD left atrium diameter corrected by aorta, HR heart rate,
CO cardiac output, E mitral E wave, A mitral A wave, E/A E wave/A wave ratio
*p < 0.05
Fidelix et al. Nutrire  (2016) 41:13 Page 4 of 7[23]. This classification considered serum levels of 25(OH)
vitamin D3 lower than 12 ng/mL as vitamin D deficiency
and lower than 20 ng/mL as risk of vitamin D inadequacy.
Studies showed high prevalence of hypovitaminosis D
in different populations worldwide, including Brazil. InTable 3 Correlation analysis for the left ventricular mass index
and posterior wall thickness
Variables r p
LVMI
Vitamin D serum (ng/mL) 0.263 0.0526
Vitamin D intake (μg/d) −0.173 0.206
BMI (kg/m2) 0.143 0.297
FMI (kg/m2) 0.097 0.478
FFMI (kg/m2) 0.127 0.356
Smoking time (years) 0.437 0.0009*
PW (mm)
Vitamin D serum (ng/mL) 0.314 0.0200*
Vitamin D intake (μg/d) −0.198 0.146
BMI (kg/m2) 0.294 0.0293*
FMI (kg/m2) 0.172 0.209
FFMI (kg/m2) 0.261 0.0543
Smoking time (years) 0.345 0.0102*
PW posterior wall thickness, LVMI left ventricular mass index, Freq Sun Expo
frequency full sun exposure, PTH parathyroid hormone, BMI body mass index,
FMI fat mass index, FFMI fat-free mass index
*p < 0.05certain Asian, European, and Latin American countries,
hypovitaminosis D (<20 ng/mL) prevalence ranged from
20 to 83 % depending on the populations studied [27]. In
Brazil, the rate of vitamin D deficiency ranged from 42 to
86 % [28–30]. In the present study, 34.5 % of participantsTable 4 Multiple linear regression model for the left ventricular
mass index and posterior wall thickness




Smoking time (years) 0.229 1.002 (0.48–1.524) <0.001*
LVMI
Vitamin D serum (ng/mL) 0.0759 0.776 (−0.016–1.568) 0.056
LVMI
Smoking time (years) 0.249 0.918 (0.378–1.458) 0.001*
Vitamin D serum (ng/mL) 0.433 (−0.317–1.183) 0.253
PW (mm)
Smoking time (years) 0.224 0.0416 (0.0148–0.0684) 0.003*
PW (mm)
Vitamin D serum (ng/mL) 0.245 0.0534 (0.0156–0.0912) 0.007*
PW (mm)
Smoking time (years) 0.310 0.0337 (0.0067–0.0607) 0.016*
Vitamin D serum (ng/mL) 0.0408 (0.0034–0.0782) 0.034*
Adjusted for age and BMI
PW posterior wall thickness, LVMI left ventricular mass index
*p < 0.05
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portion of subjects at risk for vitamin D inadequacy was
also not different among the groups. The majority of the
subjects in the present study had an adequate vitamin D
status.
Brot et al. [31] observed a higher frequency of vitamin
D deficiency (20.9 %) in the smokers compared with the
non-smokers group (13.7 %); however, we did not ob-
serve any difference. This finding and the similar serum
25(OH) vitamin D3 levels between control and smoking
groups shows that the smoking habit does not influence
vitamin D status. However, the ex-smoker group had
higher serum vitamin D levels than the control group.
This difference could be due to the higher sun exposure
observed in ex-smokers.
The interest in the association of vitamin D and car-
diovascular diseases came from animal models and epi-
demiological studies reporting increased cardiovascular
events in subjects with vitamin D deficiency [4, 32–34].
Several studies showed that vitamin D exerts a biphasic
“dose-response” curve on cardiovascular physiopathology
with deleterious consequences not only in the case of vita-
min D deficiency but also when it is in excess [35, 36].
Both vitamin D deficiency [37–41] and high vitamin D
levels [42–46] can be associated with structural and func-
tional cardiovascular alterations. In the present study, we
observed that serum 25(OH) vitamin D3 levels were asso-
ciated with PW using the linear multiple regression
model. An increase of 1 ng/mL in serum 25(OH) vitamin
D3 caused a 0.05-mm increase in PW thickness. This find-
ing suggests a deleterious consequence of high serum vita-
min D levels on the heart.
Among the cellular and molecular changes that occur
in the process of cardiac remodeling by vitamin D excess
is oxidative stress. Chen and DeLuca [47] identified a
gene (vitamin D upregulated (VDUP-1)) which is posi-
tively regulated by vitamin D promyelocytic cell line
(HL-60). The VDUP-1 has been identified in several tis-
sues including the heart [48–51]. The protein encoded by
VDUP-1 is also known as the thioredoxin-binding protein
(TBP-2) or more days, as protein interactions with thiore-
doxin (TXNIP). It was given these names because, among
other functions, it was identified as an endogenous nega-
tive regulator of protein thioredoxin (Trx), an important
antioxidant protein in the heart [52]. This interaction
blocks the binding of Trx with other factors, reducing
their reducing activity [53, 54]. Another mechanism that
might explain cardiac structural abnormalities could be
the increased secretion of fibroblast growth factor 23
(FGF-23). Increased FGF-23 is associated with left ven-
tricular hypertrophy in patients with chronic kidney dis-
ease [55, 56] and in patients with systolic heart failure
[57]. In an experimental study in which FGF-23 was ad-
ministered into mice atrium, the induction of cardiachypertrophy was observed [58]. FGF-23 is one of the hor-
mones that contributes to the regulation of serum phos-
phorus concentration [59], and it is also known that
increasing the concentration of vitamin D increases intes-
tinal absorption and serum phosphorous concentration
[46, 60].
A main health disorder linked to smoking is cardiovas-
cular disease [12, 13]. Smoking habits are reportedly asso-
ciated with cardiac remodeling [12, 13, 61], which is
associated with increased risk of heart failure and mortal-
ity. In the present study, we observed that the smoking
group had higher values of PW thickness, left ventricle
mass, and LVM index compared with the control group.
In the multiple linear regression model in which LVMI
was associated with time of smoking, each 1 year of
smoking history increased the LVMI by 1.0 g. In an-
other model, PW was associated with time of smoking,
and each year in smoking history increased PW thick-
ness by 0.04 mm. These higher LVM and PW values in
smoking subjects were also observed in other studies
[17, 62, 63].
The vitamin D-mediated protection effect against the
smoking aggression [16] was not observed in the present
study. In multiple linear regression models, we showed
that vitamin D is another factor associated with the
smoking effect in the heart.
What is new/novel about this research? Vitamin D
and smoking are risk factors for cardiovascular disease.
The present study suggests the deleterious effect of vita-
min D to the heart. High serum vitamin D concentration
is another factor associated with the action of smoking
on cardiac variables.
Some limitations of this study have to be considered.
Our study included a small number of women per
group. Furthermore, the majority of women assessed
were obese, which negatively correlates with vitamin D
concentrations. The enrollment of only women limits
the generalization of the study.Conclusions
The smoking habit of adult women was associated with
cardiac remodeling, and excess of vitamin D is associ-
ated with the action of smoking on cardiac variables.
Thus, higher serum vitamin D values have a deleterious
effect to the heart in this model.Acknowledgements
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